#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma pancreas Lymphatic malformation Non-Hodgkin's lymphoma refractory Primary hyperoxaluria Osteogenesis imperfecta Infective uveitis Palmoplantar pustulosis Follicle centre lymphoma follicular grade I II – III refractory Drug eruption Alternating hemiplegia of childhood Dermatomyositis Intracranial calcification Autoinflammation with infantile enterocolitis Glycogen storage disease type I Vulval cancer More trials…

    Learn about Rare Diseases

    SAPHO syndrome Glycogen storage disease type II Bronchiolitis obliterans syndrome – Life with Disease Myelodysplastic syndrome – Basic Information Myxofibrosarcoma – Trials in Disease Leiomyosarcoma metastatic Tuberous sclerosis complex Castleman’s disease – Basic Information Pituitary-dependent Cushing’s syndrome – Basic Information Basal cell naevus syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ribonucleic Acid Specific Nucleic Acid Sna-Xfsb Morphine Hydrochloride Loperamide Formoterol Fumarate Danazol Dexchlorpheniramine Maleate Viltolarsen Trastuzumab Emtansine Aluminium Hydroxide Corifollitropin Alfa Adagrasib Nizaracianine Triflutate Glofitamab Tretinoin CHOLINE ALFOSCERATE CAL101 Ecopipam Hydrochloride Povidone Dicloxacillin More therapies…

    Learn about Your Condition

    Cryoglobulinaemia Testis cancer Noninfective chorioretinitis Electronic cigarette user Systemic sclerosis pulmonary Lipid metabolism disorder Follicular lymphoma stage III Seizure Meniscus operation Tertiary adrenal insufficiency Bone marrow failure Acute myocardial infarction Haemorrhage prophylaxis Intestinal ischaemia Mucous membrane pemphigoid More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • Pitolisant
    Belgium Germany Italy Spain

  • Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Rozanolixizumab
    France Greece Hungary Spain

  • Diagnostic Accuracy of [68Ga]FAPI-46 PET/CT for Detecting Metastatic Lesions in Patients with Invasive Lobular Breast Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Invasive lobular breast carcinoma
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Efficacy and Safety of Photodynamic Therapy with 5‑Aminolevulinic Acid in Immunosuppressed Patients with Actinic Keratosis and Superficial Basal Cell Carcinoma

    Not yet recruiting

    3 1 1 1
    Spain

  • Diagnostic PET Study of Al[18F]F-NOTA-folate in Patients with Suspected Cardiac Sarcoidosis or Infective Endocarditis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac sarcoidosis
    • Endocarditis bacterial
    Finland

  • Efficacy of Etifoxine in Adults with Adjustment Disorder with Anxiety: A Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Etifoxine Hydrochloride
    France
Previous Page
1 … 656 657 658 659 660 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!